Evidence map›Paper›PMID 16304058›Full record

Trial reportBlood2006

Genetic variation in bactericidal/permeability-increasing protein influences the risk of developing rapid airflow decline after hematopoietic cell transplantation.

Jason W Chien, Lue Ping Zhao, John A Hansen, Wen Hong Fan, Tanyalak Parimon, Joan G Clark

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Blood, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Soluble tumor necrosis factor receptor: enbrel (etanercept) for subacute pulmonary dysfunction following allogeneic stem cell transplantation.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2012
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Small airways diseases, excluding asthma and COPD: an overview.European respiratory review : an official journal of the European Respiratory Society · 2013
    Article
  7. Article
  8. Review
  9. Innate immune activation potentiates alloimmune lung disease independent of chemokine (C-X-C motif) receptor 3.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2011
    Article
  10. Review
  11. Article
  12. Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2010
    Review
  13. Article
  14. Article
  15. Improving hematopoietic cell transplant outcomes in a new era of genomic research.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2009
    Review
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Jason W ChienPulmonary and Critical Care Section, Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave North, D5-280, Seattle, WA 98109-1024, USA. jchien@fhcrc.org
Lue Ping Zhao
John A Hansen
Wen Hong Fan
Tanyalak Parimon
Joan G Clark
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZA

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian Esvelt · 1985 to 2026
$296.4M
VIRUS-MEDIATED MYELOSUPPRESSIONP01CA018029 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Geoffrey Roger HILL · 1985 to 2026
$128.4M
TRANSPLANTATION IMMUNOLOGYP01AI033484 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MARTIN, PAUL J · 1992 to 2013
$13.1M
Methods for Correlating SNP Haplotypes with CancerR01CA106320 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ZHAO, LUE PING · 2004 to 2008
$1.9M
Genetic epidemiology of TLR4 alleles and bacteremiaK23HL069860 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI CHIEN, JASON W · 2002 to 2006
$776k
Genetic Risk Factors for Airflow Obstruction after HSCTR01HL071914 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI CLARK, JOAN G. · 2002 to 2003
$346k
NCI NIH HHS CA106320NCI NIH HHS CA15704NCI NIH HHS CA18029NHLBI NIH HHS HL71914NHLBI NIH HHS K23HL69860NIAID NIH HHS AI33484
6 · The paper itself

Abstract

Innate immunity is involved in the biology of graft versus host disease and common airway diseases. We screened 15 genes in this pathway using a linkage disequilibrium-based approach to identify potential candidate genes that may be involved in the development of airflow obstruction after hematopoietic cell transplantation. Sixty-nine single-nucleotide polymorphisms were selected for assessment in a discovery cohort (n = 363). Significant associations were validated in a validation cohort (n = 209). Expression of the candidate gene was demonstrated by detecting gene transcript and protein in malignant and normal small airway epithelial cells. In the discovery cohort, 133 patients developed significant airflow decline. Four patient and donor bactericidal/permeability-increasing (BPI) haplotypes were associated with a 2-fold to 3-fold increased risk of developing significant airflow decline (P values, .004-.038). This association was confirmed in the validation cohort, which had 66 patients with significant airflow decline, with 9 significant haplotypes (P values, .013-.043). BPI gene transcript and protein were detected in airway epithelial cells. These results suggest mutations in the BPI gene significantly influence the risk of developing rapid airflow decline after hematopoietic cell transplantation and may represent a novel therapeutic target for this form of airway disease.

Indexed as

Hematopoietic Stem Cell TransplantationPolymorphism, Single NucleotideAdultAntimicrobial Cationic PeptidesBlood ProteinsCohort StudiesFemaleGraft vs Host DiseaseHaplotypesHematologic NeoplasmsHumansMaleMembrane ProteinsMiddle AgedRespiratory Tract DiseasesRisk FactorsAntimicrobial Cationic Peptidesbactericidal permeability increasing proteinBlood ProteinsMembrane Proteins

Identifiers

PMID16304058
PMCPMC1895720
OpenAlexW2039442298

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.